New Delhi: The Union government has announced a pioneering clinical study to investigate whether Ayurveda can enhance recovery in tuberculosis (TB) patients when used alongside standard anti-TB treatment. The initiative, revealed on World Tuberculosis Day, aims to examine the impact of traditional therapies on nutrition, immunity, and overall quality of life for patients undergoing long-term TB therapy.
Tuberculosis treatment often extends beyond completing months of medication. Many patients continue to experience weight loss, fatigue, and delayed recovery even after the infection is controlled. Health experts note that restoring overall health and immunity is a critical part of TB management, not just eliminating the bacteria.
The newly announced initiative, titled “Clinical Study on Ayurveda as an Adjunct Therapy for Tuberculosis”, is a collaborative effort between the Ministry of AYUSH and the Department of Biotechnology. The study will be conducted across leading institutions, including AIIMS, JIPMER, and the North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences.
Integrating Traditional Knowledge with Modern Science
Union Minister Jitendra Singh highlighted that India’s fight against TB is increasingly guided by research and innovation. “This study reflects our commitment to science-led, evidence-based integration of modern medicine and validated traditional knowledge systems,” he said. He also noted ongoing efforts to address major TB challenges such as drug resistance, undernutrition, and long-term health impacts.
Ayush Ministry officials emphasized that the study focuses not only on infection control but also on patient well-being. Minister of State for AYUSH Prataprao Jadhav remarked, “The treatment of TB is not only about eliminating the infection but about making the patient completely healthy. Ayurveda and other traditional therapies can play a supportive role in improving recovery, nutrition, and quality of life.”
Evidence Before Adoption
Experts stressed that Ayurveda is being explored only as a complementary therapy, not a replacement for conventional anti-TB treatment. Dr. Sundararajaperumal Anandakrishnan, Professor at Madras Medical College, said, “This is an evidence-based study to assess Ayurveda as an adjunct. The specific formulations and treatment protocols are yet to be revealed, and any conclusions must wait until the study is completed and evaluated.”
Medical specialists also underscored the importance of rigorous evaluation. Dr. Sameer Bansal, senior consultant pulmonologist at Apollo Hospital, Bengaluru, welcomed the initiative, noting India’s high TB burden and the need for original research. “While promising, it is important to ensure that the study produces solid scientific outcomes rather than merely promoting an AYUSH agenda,” he said, highlighting ongoing challenges such as inconsistent drug supply, therapy monitoring, and testing limitations.
Nutrition and immunity are recognized as essential factors in TB recovery. Dr. Surendran R, infectious diseases consultant at SIMS Hospital, Chennai, pointed out that protein-rich diets and dietitian support are already part of standard care. “Exploring Ayurvedic medicines as supportive therapy for immunity, nutrition, and weight management is a new approach. Its effectiveness will be known only after careful analysis of the study results,” he said.
The multi-center study is expected to provide clarity on whether integrative approaches can enhance TB recovery, offering potential guidance for future patient care strategies in India and beyond.